Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals.
Published June 14, 2017 · Recall initiated: March 14, 2017
Summary
FDA records medical device Class II recall Z-2319-2017, published June 14, 2017 and initiated March 14, 2017. Recalling firm: Nexstim PLC; Status: Ongoing; Reported quantity: 11 units.; Lot: Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Software defect: the NBS software may accidentally generate duplicate copies of one or several files.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Nexstim PLC
- Distributor
- Worldwide Distribution - US to GA only, Foreign: Europe
- Lot
- Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Finland
Related recalls
- FDALevophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest,June 21, 2017
- FDANBS System 4 (sw version 4.0 or higher), Software update to 4.3.3 and NBS System 5 (sw version 5.0 or higher),June 14, 2017
- FDADePuy Synthes various orthopedic instruments modified by U.S. Distributors These instruments are used inJune 14, 2017
- FDAMedTest DX Assayed Human Multi Sera Control Level 1 (HNC200) and Level 2 (HEC200) HEC200 " Sml amber glassJune 14, 2017
- FDAResponse BandLoc 5.5/6.0 Tensioner Instrument The Tensioner Instrument (01-1102-1000) is utilized to allow theJune 14, 2017
- FDALapSac Introducer, Supplied sterilized by ethylene oxide gas in peel-open packages. Used to aid in theJune 14, 2017
Questions about this recall
Was Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals. recalled?
Yes. FDA published recall Z-2319-2017 on June 14, 2017. Reported hazard: Software defect: the NBS software may accidentally generate duplicate copies of one or several files.
What should I do if I have this product?
Voluntary: Firm initiated · Letter